Sep 8, 2026 06:01AM
Sep 8, 2026 06:00AM
Sep 8, 2026 06:00AM
Sep 8, 2026 06:00AM
Sep 6, 2026 01:00AM
Sep 6, 2026 01:00AM
Sep 6, 2026 01:00AM Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on T
Sep 6, 2026 01:00AM
Aug 27, 2026 03:29PM
Aug 27, 2026 03:29PM
Aug 27, 2026 03:29PM
Aug 27, 2026 03:28PM
Aug 27, 2026 03:28PM
Aug 27, 2026 03:28PM Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
Aug 6, 2026 07:00AM
Aug 6, 2026 07:00AM
Aug 6, 2026 07:00AM
Jul 23, 2026 04:05PM
May 21, 2026 09:17AM
May 21, 2026 06:20AM
May 20, 2026 07:00AM Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update
Apr 2, 2026 05:00AM
Apr 2, 2026 05:00AM
Apr 2, 2026 05:00AM
Apr 2, 2026 05:00AM
Mar 28, 2026 03:00PM
Mar 28, 2026 03:00PM
Mar 3, 2026 07:00AM FDA accepts Priovant's drug application for dermatomyositis treatment
Mar 3, 2026 07:00AM
Feb 10, 2026 06:52AM
Feb 6, 2026 07:00AM
Feb 6, 2026 07:00AM
Feb 6, 2026 07:00AM
Feb 6, 2026 07:00AM
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Oct 1, 2025 01:13PM
Sep 3, 2025 01:01PM
Sep 3, 2025 01:01PM
Apr 21, 2025 07:02AM
Apr 21, 2025 07:00AM
Nov 12, 2024 07:00AM
Oct 28, 2024 09:25AM Organon (OGN) Completes Acquisition of Dermavant
Oct 28, 2024 09:25AM
Sep 18, 2024 07:30AM
Sep 18, 2024 07:30AM
Sep 11, 2024 06:36AM
Sep 9, 2024 07:02AM
Sep 9, 2024 07:00AM
Aug 8, 2024 07:00AM Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update
May 30, 2024 07:00AM

330,635 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All